Alacrity Biosciences, Inc.
🇺🇸United States
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for a 56 Day Period
- First Posted Date
- 2007-02-23
- Last Posted Date
- 2007-10-02
- Lead Sponsor
- Alacrity Biosciences, Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT00439400
- Locations
- 🇺🇸
Ophthalmic Research Associates, Andover, Massachusetts, United States
News
No news found